These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23229447)

  • 1. The role of IL-17-secreting mast cells in inflammatory joint disease.
    Kenna TJ; Brown MA
    Nat Rev Rheumatol; 2013 Jun; 9(6):375-9. PubMed ID: 23229447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1.
    Nigrovic PA; Binstadt BA; Monach PA; Johnsen A; Gurish M; Iwakura Y; Benoist C; Mathis D; Lee DM
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2325-30. PubMed ID: 17277081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.
    Guma M; Kashiwakura J; Crain B; Kawakami Y; Beutler B; Firestein GS; Kawakami T; Karin M; Corr M
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22122-7. PubMed ID: 21135226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4-mediated IL-12 production enhances IFN-γ and IL-1β production, which inhibits TGF-β production and promotes antibody-induced joint inflammation.
    Kim HS; Chung DH
    Arthritis Res Ther; 2012 Oct; 14(5):R210. PubMed ID: 23036692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Noordenbos T; Yeremenko N; Gofita I; van de Sande M; Tak PP; Caňete JD; Baeten D
    Arthritis Rheum; 2012 Jan; 64(1):99-109. PubMed ID: 21968742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
    Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mast cells capture, store, and release bioactive, exogenous IL-17A.
    Noordenbos T; Blijdorp I; Chen S; Stap J; Mul E; Cañete JD; Lubberts E; Yeremenko N; Baeten D
    J Leukoc Biol; 2016 Sep; 100(3):453-62. PubMed ID: 27034403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4.
    Gondokaryono SP; Ushio H; Niyonsaba F; Hara M; Takenaka H; Jayawardana ST; Ikeda S; Okumura K; Ogawa H
    J Leukoc Biol; 2007 Sep; 82(3):657-65. PubMed ID: 17575266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of proteoglycan-induced arthritis is independent of IL-17.
    Doodes PD; Cao Y; Hamel KM; Wang Y; Farkas B; Iwakura Y; Finnegan A
    J Immunol; 2008 Jul; 181(1):329-37. PubMed ID: 18566398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.
    Marshall JS; Leal-Berumen I; Nielsen L; Glibetic M; Jordana M
    J Clin Invest; 1996 Feb; 97(4):1122-8. PubMed ID: 8613537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9.
    Hültner L; Kölsch S; Stassen M; Kaspers U; Kremer JP; Mailhammer R; Moeller J; Broszeit H; Schmitt E
    J Immunol; 2000 Jun; 164(11):5556-63. PubMed ID: 10820229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint inflammation and cartilage destruction may occur uncoupled.
    van den Berg WB
    Springer Semin Immunopathol; 1998; 20(1-2):149-64. PubMed ID: 9836374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
    Hsu CL; Neilsen CV; Bryce PJ
    PLoS One; 2010 Aug; 5(8):e11944. PubMed ID: 20689814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Carinci F; Ronconi G; Kritas SK; Di Emidio P; Martinotti S; Pandolfi F
    Crit Rev Immunol; 2019; 39(4):267-274. PubMed ID: 32421968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Oriental medicine "Cool-Cool (Cool-X-A)" inhibits inflammatory cytokine production and migration in mast cells.
    Kim MS; Choi IY; Lee SH; Hong SH; Shin T; Kim HM
    Biol Pharm Bull; 2004 Jan; 27(1):34-7. PubMed ID: 14709895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis.
    Kan J; Mishima S; Kashiwakura J; Sasaki-Sakamoto T; Seki M; Saito S; Ra C; Tokuhashi Y; Okayama Y
    Allergol Int; 2016 Sep; 65 Suppl():S11-6. PubMed ID: 27209051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.